This article is more than 5 years old. Information may no longer be current.
Study: Atropine slows myopia progression more in Asian than white children
Click Here to Manage Email Alerts
Researchers who analyzed the effects of atropine in slowing myopia progression in Asian and white children found that atropine could significantly slow myopia progression in children, with stronger effects in Asian children.
Li and colleagues included four randomized controlled trials and seven cohort studies involving 1,815 children ages 5 to 15 years that were conducted over a 12- to 36-month period. The baseline refraction for all children was -0.50 D to -9.75 D.
The study found, that when compared with a placebo, the risk of fast myopia progression using atropine was lowered by at least 1 D in all trials, and the benefit of slow myopia progression, considered to be less than 0.50 D per year, using atropine was significantly increased as well.
Li and colleagues concluded, “Atropine could significantly slow myopia progression in children, with greater effects in Asian than in white children.”
Click Here to Manage Email Alerts